Your browser doesn't support javascript.
loading
Targeted Temperature Management After In-Hospital Cardiac Arrest: An Ancillary Analysis of Targeted Temperature Management for Cardiac Arrest With Nonshockable Rhythm Trial Data.
Blanc, Alexiane; Colin, Gwenhael; Cariou, Alain; Merdji, Hamid; Grillet, Guillaume; Girardie, Patrick; Coupez, Elisabeth; Dequin, Pierre-François; Boulain, Thierry; Frat, Jean-Pierre; Asfar, Pierre; Pichon, Nicolas; Landais, Mickael; Plantefeve, Gaëtan; Quenot, Jean-Pierre; Chakarian, Jean-Charles; Sirodot, Michel; Legriel, Stéphane; Massart, Nicolas; Thevenin, Didier; Desachy, Arnaud; Delahaye, Arnaud; Botoc, Vlad; Vimeux, Sylvie; Martino, Frederic; Reignier, Jean; Taccone, F S; Lascarrou, J B.
Afiliación
  • Blanc A; Médecine Intensive Réanimation, University Hospital Center, Nantes, France.
  • Colin G; Medical-Surgical Intensive Care Unit, District Hospital Center, La Roche-sur-Yon, France.
  • Cariou A; Paris Cardiovascular Research Center, INSERM U970, Paris, France; Medical Intensive Care Unit, Cochin University Hospital Center, Paris, France; AfterROSC Network, Cochin University Hospital Center, Paris, France.
  • Merdji H; Faculté de Médecine Université de Strasbourg (UNISTRA) and the Service de Médecine Intensive Réanimation (H. Merdji), Nouvel Hôpital Civil, Hôpitaux universitaires de Strasbourg, Strasbourg, France; UMR 1260, Regenerative Nano Medecine, INSERM, Fédération de Médecine Translationnelle de Strasbourg (
  • Grillet G; Medical Intensive Care Unit, South Brittany General Hospital Center, Lorient, France.
  • Girardie P; Médecine Intensive Réanimation, CHU Lille, and the Université de Lille, Faculté de Médicine, Lille, France.
  • Coupez E; Medical Intensive Care Unit, University Hospital Center, Clermond-Ferrand, France.
  • Dequin PF; Medical Intensive Care Unit, University Hospital Center, Tours, France; Inserm UMR 1100-Centre d'Étude des Pathologies Respiratoires, Tours University, Tours, France.
  • Boulain T; Medical Intensive Care Unit, Regional Hospital Center, Orleans, France.
  • Frat JP; Medical Intensive Care Unit, University Hospital Center, Poitiers, France; INSERM, CIC-1402, Équipe ALIVE, Poitiers, France; Faculté de Médecine et de Pharmacie de Poitiers, Université de Poitiers, Poitiers, France.
  • Asfar P; Medical Intensive Care Unit, University Hospital Center, Angers, France.
  • Pichon N; AfterROSC Network, Cochin University Hospital Center, Paris, France; Service de Réanimation Polyvalente, University Hospital Center, Limoges, France; CIC 1435, University Hospital Center, Limoges, France.
  • Landais M; Medical-Surgical Intensive Care Unit, General Hospital Center, Le Mans, France.
  • Plantefeve G; Medical-Surgical Intensive Care Unit, General Hospital Center, Argenteuil, France.
  • Quenot JP; Medical Intensive Care Unit, University Hospital Center, Dijon, France.
  • Chakarian JC; Medical-Surgical Intensive Care Unit, General Hospital Center, Roanne, France.
  • Sirodot M; Medical-Surgical Intensive Care Unit, General Hospital Center, Annecy, France.
  • Legriel S; AfterROSC Network, Cochin University Hospital Center, Paris, France; Medical-Surgical Intensive Care Unit, Versailles Hospital, Versailles, France.
  • Massart N; Medical-Surgical Intensive Care Unit, General Hospital Center, Saint Brieuc, France.
  • Thevenin D; Medical-Surgical Intensive Care Unit, General Hospital Center, Lens, France.
  • Desachy A; Medical-Surgical Intensive Care Unit, General Hospital Center, Angouleme, France.
  • Delahaye A; Medical-Surgical Intensive Care Unit, General Hospital Center, Rodez, France.
  • Botoc V; Medical-Surgical Intensive Care Unit, General Hospital Center, Saint Malo, France.
  • Vimeux S; Medical-Surgical Intensive Care Unit, General Hospital Center, Montauban, France.
  • Martino F; Medical Intensive Care Unit, University Hospital Center, Pointe-à-Pitre, France.
  • Reignier J; Médecine Intensive Réanimation, University Hospital Center, Nantes, France.
  • Taccone FS; Erasmus University Hospital, Free University of Brussels, Brussels, Belgium.
  • Lascarrou JB; Médecine Intensive Réanimation, University Hospital Center, Nantes, France; Paris Cardiovascular Research Center, INSERM U970, Paris, France; AfterROSC Network, Cochin University Hospital Center, Paris, France. Electronic address: jeanbaptiste.lascarrou@chu-nantes.fr.
Chest ; 162(2): 356-366, 2022 08.
Article en En | MEDLINE | ID: mdl-35318006
ABSTRACT

BACKGROUND:

Targeted temperature management (TTM) currently is the only treatment with demonstrated efficacy in attenuating the harmful effects on the brain of ischemia-reperfusion injury after cardiac arrest. However, whether TTM is beneficial in the subset of patients with in-hospital cardiac arrest (IHCA) remains unclear. RESEARCH QUESTION Is TTM at 33 °C associated with better neurological outcomes after IHCA in a nonshockable rhythm compared with targeted normothermia (TN; 37 °C)? STUDY DESIGN AND

METHODS:

We performed a post hoc analysis of data from the published Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm randomized controlled trial in 584 patients. We included the 159 patients with IHCA; 73 were randomized to 33 °C treatment and 86 were randomized to 37 °C treatment. The primary outcome was survival with a good neurologic outcome (cerebral performance category [CPC] score of 1 or 2) on day 90. Mixed multivariate adjusted logistic regression analysis was performed to determine whether survival with CPC score of 1 or 2 on day 90 was associated with type of temperature management after adjustment on baseline characteristics not balanced by randomization.

RESULTS:

Compared with TN for 48 h, hypothermia at 33 °C for 24 h was associated with a higher percentage of patients who were alive with good neurologic outcomes on day 90 (16.4% vs 5.8%; P = .03). Day 90 mortality was not significantly different between the two groups (68.5% vs 76.7%; P = .24). By mixed multivariate analysis adjusted by Cardiac Arrest Hospital Prognosis score and circulatory shock status, hypothermia was associated significantly with good day 90 neurologic outcomes (OR, 2.40 [95% CI, 1.17-13.03]; P = .03).

INTERPRETATION:

Hypothermia at 33 °C was associated with better day 90 neurologic outcomes after IHCA in a nonshockable rhythm compared with TN. However, the limited sample size resulted in wide CIs. Further studies of patients after cardiac arrest resulting from any cause, including IHCA, are needed.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Reanimación Cardiopulmonar / Paro Cardíaco Extrahospitalario / Hipotermia / Hipotermia Inducida Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Chest Año: 2022 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Reanimación Cardiopulmonar / Paro Cardíaco Extrahospitalario / Hipotermia / Hipotermia Inducida Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Chest Año: 2022 Tipo del documento: Article País de afiliación: Francia